Skip to content

Heterozygous familial hypercholesterolemia in Italian children: a road map through a single center’s experience

Oct 2026 · European Journal of Pediatrics · Vol 185 · 0 citations · 17 references
Medicine

TL;DR

The findings support the clinical value of genetic testing in familial hypercholesterolemia, both for improving diagnostic accuracy and for promoting earlier therapeutic intervention and adherence.

View source

Similar papers

Open access Oct 2026

Lipoprotein(a) levels in children with genetically confirmed heterozygous familial hypercholesterolaemia

Heterozygous familial hypercholesterolemia (HeFH) is an autosomal dominant disorder characterized by elevated LDL-cholesterol (LDL-C) levels from childhood. Increased lipoprotein(a)[Lp(a)] levels, a genetically determined risk factor for atherosclerotic events, may influence the clinical presentation of FH. Howev...

K. M. B. Borges, F. Juliani, M. Castelo et al. · 0 citations
Review Open access Sep 2026

FAMILIAL HYPERCHOLESTEROLEMIA IN YOUNG ADULTS: CHALLENGES IN DIAGNOSIS AND IMPLEMENTATION OF CURRENT GUIDELINES – A NARRATIVE REVIEW

Background. Familial hypercholesterolemia (FH) is a common autosomal dominant genetic disorder associated with premature atherosclerotic cardiovascular disease. Despite established international guidelines, FH remains substantially underdiagnosed, particularly in young adults. Aim. This narrative review summarizes curr...

Jakub Dyczko, Filip Kruczek, K. Mączka et al. · 0 citations
Review Open access Oct 2026

Towards a suitable biomarker for childhood screening for familial hypercholesterolemia: a systematic literature review

Abstract Familial hypercholesterolemia (FH) is a common genetic disorder causing elevated low-density lipoprotein cholesterol (LDL-c) concentrations from birth, resulting in a high risk of premature cardiovascular disease. Despite effective early treatment, FH remains underdiagnosed in children, highlighting the need f...

Vera H. de Kleijne, B. Hutten, A. Boelen et al. · 0 citations
Review Open access Sep 2026

Current challenges in diagnosing homozygous familial hypercholesterolemia: Insights from the historical evolution of diagnostic criteria.

As the diagnosis of HoFH continues to evolve, future diagnostic criteria should place less emphasis on genetics and greater emphasis on modern clinical applications to ensure that all individuals with HoFH have access to the most appropriate therapies to reduce their risk of premature ASCVD and death resulting from pro...

Daniel Gaudet, R. Godin, R. Rosenson et al. · 0 citations
Open access Sep 2026

LDL hypercholesterolemia in children: genetic influence and response to lifestyle advice - follow-up of the Fr1dolin-trial

One-time nutritional advice had little effect on LDL-C in general, but particularly in FH, highlighting on the one hand need for structured lifestyle programs and on the other hand early genetic testing in population based FH screening.

S. Arens, U. Šuštar, K. Lange et al. · 0 citations
Open access Aug 2026

Reverse Cascade Genetic Screening for Revealing New Cases of Familial Hypercholesterolemia in Russia: Pilot Project.

BACKGROUND Reverse cascade genetic screening, following initial lipid testing, is an effective strategy for the early diagnosis of familial hypercholesterolemia (FH) and related hereditary dyslipidemias. In this study, we present the results of a pilot project in Russia. METHODS This was a hybrid retrospective-prospe...

V. Miroshnikova, A. Izyumchenko, N. N. Smirnova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.